Those aspiring to outpace the market meticulously engage in the process of selecting individual stocks. Strategic choices can be instrumental in accelerating your wealth.
The price of Elevation Oncology Inc (NASDAQ: ELEV) closed at $0.47 in the last session, down -7.89% from day before closing price of $0.51. In other words, the price has decreased by -$7.89 from its previous closing price. On the day, 1.0 million shares were traded.
Ratios:
We take a closer look at ELEV’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 21.21 and its Current Ratio is at 21.21. In the meantime, Its Debt-to-Equity ratio is 0.52 whereas as Long-Term Debt/Eq ratio is at 0.52.
On May 31, 2024, Piper Sandler started tracking the stock assigning a Overweight rating and target price of $10.
On May 14, 2024, Stephens started tracking the stock assigning a Overweight rating and target price of $8.Stephens initiated its Overweight rating on May 14, 2024, with a $8 target price.
Stock Price History:
Over the past 52 weeks, ELEV has reached a high of $5.83, while it has fallen to a 52-week low of $0.41. The 50-Day Moving Average of the stock is -25.14%, while the 200-Day Moving Average is calculated to be -62.50%.
Shares Statistics:
A total of 59.13M shares are outstanding, with a floating share count of 52.07M. Insiders hold about 12.07% of the company’s shares, while institutions hold 56.02% stake in the company.
